High Medication Prices: The Keytruda Case

The cancer medication Keytruda is a focal point in the debate regarding high medication prices in Switzerland. The discussion focuses on the implications of pricing and profits within the pharmaceutical industry, raising concerns about accessibility and affordability for patients. This case has prompted public discussion on the broader issues of healthcare costs and the sustainability of drug pricing models in the country.